NCT00500539 · Interventional trial
Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.
Overall registry status Completed
Phase 3
Conditions Asthma
Delaware Valley sites
- Asthma Allergy & Pulmonary Associates, PC · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory